BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 25476748)

  • 1. Significant differences between vascular and nonvascular surgeons in the perioperative management of antiplatelet therapies in patients with coronary stents.
    Kilic A; Sultan IS; Arnaoutakis GJ; Black JH; Reifsnyder T
    Ann Vasc Surg; 2015 Apr; 29(3):526-33.e2. PubMed ID: 25476748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-eluting stents versus bare metal stents prior to noncardiac surgery.
    Bangalore S; Silbaugh TS; Normand SL; Lovett AF; Welt FG; Resnic FS
    Catheter Cardiovasc Interv; 2015 Mar; 85(4):533-41. PubMed ID: 25059742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary stents and subsequent surgery: reported provider attitudes and practice patterns.
    Graham LA; Maddox TM; Itani KM; Hawn MT
    Am Surg; 2013 May; 79(5):514-23. PubMed ID: 23635588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
    Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS
    JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding operator stent choice in the catheterization laboratory using a pre-procedure survey: Opportunities for quality improvement.
    Chung MJ; Hansen JD; Schulteis RD; Boggan JC; Jones WS; Povsic TJ; Roberts S; Krucoff MW; Rao SV
    Cardiovasc Revasc Med; 2017 Dec; 18(8):588-591. PubMed ID: 28529095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2.
    Rossini R; Tarantini G; Musumeci G; Masiero G; Barbato E; Calabrò P; Capodanno D; Leonardi S; Lettino M; Limbruno U; Menozzi A; Marchese UOA; Saia F; Valgimigli M; Ageno W; Falanga A; Corcione A; Locatelli A; Montorsi M; Piazza D; Stella A; Bozzani A; Parolari A; Carone R; Angiolillo DJ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
    JACC Cardiovasc Interv; 2018 Mar; 11(5):417-434. PubMed ID: 29519377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Perioperative management of antiplatelet therapy in thoracic surgery. A survey of German hospitals].
    Wiesemann S; Passlick B
    Chirurg; 2012 Jun; 83(6):576-82. PubMed ID: 22327953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease.
    Puymirat E; Mangiacapra F; Peace A; Ntarladimas Y; Conte M; Bartunek J; Vanderheyden M; Wijns W; de Bruyne B; Barbato E
    Arch Cardiovasc Dis; 2013 Nov; 106(11):554-61. PubMed ID: 24231052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
    Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual antiplatelet therapy with aspirin and clopidogrel: what is the risk in noncardiac surgery? A narrative review.
    Finkel JB; Marhefka GD; Weitz HH
    Hosp Pract (1995); 2013 Feb; 41(1):79-88. PubMed ID: 23466970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary approaches to perioperative management of coronary stents and to preoperative coronary revascularization: a survey of 374 interventional cardiologists.
    Khair T; Garcia B; Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2011; 12(2):99-104. PubMed ID: 21421188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-hospital and one year outcomes with drug-eluting versus bare metal stents in large native coronary arteries: a report from the Evaluation of Drug-Eluting Stents and Ischemic Events registry.
    Gordon PC; Cohen DJ; Kleiman NS; Montgomery JA; Semder CA; Kennedy KF; Keyes MJ; Piana RN;
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E356-64. PubMed ID: 22511502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term follow-up of tirofiban as alternative therapy for urgent surgery patients with an implanted coronary drug-eluting stent after ST-elevation myocardial infarction.
    Xia JG; Qu Y; Shen H; Liu XH
    Coron Artery Dis; 2013 Sep; 24(6):522-6. PubMed ID: 23900046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients.
    Tada T; Byrne RA; Simunovic I; King LA; Cassese S; Joner M; Fusaro M; Schneider S; Schulz S; Ibrahim T; Ott I; Massberg S; Laugwitz KL; Kastrati A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1267-74. PubMed ID: 24355117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deployment of drug-eluting stents for isolated proximal lad disease is associated with lower major adverse cardiac events and no increase in stent thrombosis when compared with bare metal stents: a 5-year observational cohort study.
    Jones DA; Rathod KS; Gallagher S; Weerackody R; Knight CJ; Rothman MT; Mathur A; Jain AK; Timmis AD; Wragg A
    Catheter Cardiovasc Interv; 2013 May; 81(6):E237-44. PubMed ID: 22707383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and outcome of surgical procedures after coronary bare-metal and drug-eluting stent implantation: a report from the CREDO-Kyoto PCI/CABG registry cohort-2.
    Tokushige A; Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Kadota K; Iwabuchi M; Shizuta S; Tada T; Tazaki J; Kato Y; Hayano M; Abe M; Ehara N; Inada T; Kaburagi S; Hamasaki S; Tei C; Nakashima H; Ogawa H; Tatami R; Suwa S; Takizawa A; Nohara R; Fujiwara H; Mitsudo K; Nobuyoshi M; Kita T; Kimura T;
    Circ Cardiovasc Interv; 2012 Apr; 5(2):237-46. PubMed ID: 22396582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Coronary stenting and surgery: perioperative management of antiplatelet therapy in patients undergoing surgery after coronary stent implantation].
    Rossini R; Bramucci E; Castiglioni B; De Servi S; Lettieri C; Lettino M; Musumeci G; Visconti LO; Piccaluga E; Savonitto S; Trabattoni D; Buffoli F; Angiolillo DJ; Bovenzi F; Cremonesi A; Scherillo M; Guagliumi G; ;
    G Ital Cardiol (Rome); 2012; 13(7-8):528-51. PubMed ID: 22781382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of Antiplatelet Therapy During Noncardiac Surgery in Patients With Second-Generation Drug-Eluting Stents.
    Kim C; Kim JS; Kim H; Ahn SG; Cho S; Lee OH; Park JK; Shin S; Moon JY; Won H; Suh Y; Cho JR; Cho YH; Oh SJ; Lee BK; Hong SJ; Shin DH; Ahn CM; Kim BK; Ko YG; Choi D; Hong MK; Jang Y
    J Am Heart Assoc; 2020 Jun; 9(11):e016218. PubMed ID: 32419586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peri-operative management of antiplatelet therapy in patients with coronary artery disease: joint position paper by members of the working group on Perioperative Haemostasis of the Society on Thrombosis and Haemostasis Research (GTH), the working group on Perioperative Coagulation of the Austrian Society for Anesthesiology, Resuscitation and Intensive Care (ÖGARI) and the Working Group Thrombosis of the European Society for Cardiology (ESC).
    Korte W; Cattaneo M; Chassot PG; Eichinger S; von Heymann C; Hofmann N; Rickli H; Spannagl M; Ziegler B; Verheugt F; Huber K
    Thromb Haemost; 2011 May; 105(5):743-9. PubMed ID: 21437351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preference for oral anticoagulation therapy for patients with atrial fibrillation in Europe in different clinical situations: results of the European Heart Rhythm Association Survey.
    Larsen TB; Potpara T; Dagres N; Proclemer A; Sciarrafia E; Blomström-Lundqvist C;
    Europace; 2015 May; 17(5):819-24. PubMed ID: 25926476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.